Gene expression of reprogrammed cancer cells <i>in vivo</i>.
- Hisataka Ogawa (738260)
- Xin Wu (10164)
- Koichi Kawamoto (738261)
- Naohiro Nishida (503603)
- Masamitsu Konno (738262)
- Jun Koseki (738263)
- Hidetoshi Matsui (738264)
- Kozou Noguchi (738265)
- Noriko Gotoh (133877)
- Tsuyoshi Yamamoto (738266)
- Kanjiro Miyata (738267)
- Nobuhiro Nishiyama (338219)
- Hiroaki Nagano (282467)
- Hirofumi Yamamoto (1614)
- Satoshi Obika (738268)
- Kazunori Kataoka (281782)
- Yuichiro Doki (402704)
- Masaki Mori (30875)
- Hideshi Ishii (30870)
Publication date
May 2015
DOIAbstract
<p>A) Relative expression of the differentiation-related genes PPARγ, TUBB3, VILLIN and MUC2 in the indicated experimental groups. Data are shown in comparison with the negative control (NC) miR group. (n = 3). B, C) Relative expression of CDK2, C-MYC and CDH1 (B) and epigenetic regulators AOF1, MECP1 and MECP2 (C) in the indicated experimental groups. Data are shown in comparison with the NC miR group. (n = 3). D) Relative global histone 3 lysine-4 methylation status of xenografts. Data are shown in comparison with the NC miR group. (n = 3). Asterisk denotes a p-value in the Student t-test < 0.05 (mean ± s.e.m.).</p
Add to ORKG